Osteopore Ltd. (AU:OSX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Osteopore Limited, an Australian-Singaporean medical tech firm specializing in 3D-printed bone regenerative implants, has elevated CEO Dr. Yujing Lim to the role of Executive Director. Dr. Lim’s tenure as CEO has been marked by significant partnerships, expansion into new markets, and six consecutive quarters of revenue growth. His appointment is expected to further advance the company’s strategic direction and technological innovation in the regenerative medicine sector.
For further insights into AU:OSX stock, check out TipRanks’ Stock Analysis page.